XML 67 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Reportable Segments and Major Concentration Data - Segment Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Segment Reporting Information [Line Items]                      
Net revenues $ 53,100 $ 51,737 $ 56,451 $ 52,283 $ 49,697 $ 50,140 $ 54,125 $ 46,809 $ 213,571 $ 200,771 $ 196,082
Operating income                 31,584 37,382 51,378
Depreciation and amortization                 8,688 9,090 7,718
Capital expenditures                 4,201 4,467 4,004
Goodwill 54,637       54,926       54,637 54,926 61,982
Other intangible assets 23,113       26,704       23,113 26,704 29,855
Total assets 251,377       249,777       251,377 249,777 252,028
Restructuring and litigation costs                 13,051 762  
Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 150,454 143,521 145,114
Life Science [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 63,117 57,250 50,968
Operating Segments [Member] | Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 150,454 143,521 145,114
Operating income                 29,701 23,848 38,202
Depreciation and amortization                 6,557 7,037 5,471
Capital expenditures                 2,477 2,554 2,690
Goodwill 35,213       35,213       35,213 35,213 42,608
Other intangible assets 22,068       24,973       22,068 24,973 27,534
Total assets 180,978       180,226       180,978 180,226 185,446
Net revenues                 392 389 289
Operating Segments [Member] | Life Science [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 63,117 57,250 50,968
Operating income                 14,912 14,086 12,997
Depreciation and amortization                 2,131 2,053 2,247
Capital expenditures                 1,724 1,913 1,314
Goodwill 19,424       19,713       19,424 19,713 19,374
Other intangible assets 1,045       1,731       1,045 1,731 2,321
Total assets 70,341       69,938       70,341 69,938 66,624
Net revenues                 397 537 893
Unallocated Costs and Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Operating income                 (13,029) (552) 179
Total assets $ 58       $ (387)       58 (387) (42)
Net revenues                 (789) (926) $ (1,182)
Unallocated Costs [Member]                      
Segment Reporting Information [Line Items]                      
Restructuring and litigation costs                 $ 13,051 $ 762